Aoun E - Search Results

1

Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center.

Aoun E, Shamseddine A, Chehal A, Obeid M, Taher A. Aoun E, et al. Transfusion. 2003 Dec;43(12):1672-6. doi: 10.1046/j.0041-1132.2003.00578.x. Transfusion. 2003. PMID: 14641862

2

Thrombotic thrombocytopenic purpura: 24 years of experience at the American University of Beirut Medical Center.

Shamseddine A, Saliba T, Aoun E, Chahal A, El-Saghir N, Salem Z, Bazarbachi A, Khalil M, Taher A. Shamseddine A, et al. Among authors: aoun e. J Clin Apher. 2004;19(3):119-24. doi: 10.1002/jca.20004. J Clin Apher. 2004. PMID: 15493057

3

Hypertransfusion: a successful method of treatment in thalassemia intermedia patients with spinal cord compression secondary to extramedullary hematopoiesis.

Chehal A, Aoun E, Koussa S, Skoury H, Koussa S, Taher A. Chehal A, et al. Among authors: aoun e. Spine (Phila Pa 1976). 2003 Jul 1;28(13):E245-9. doi: 10.1097/01.BRS.0000067282.47308.4D. Spine (Phila Pa 1976). 2003. PMID: 12838112

4

Use of recombinant activated factor VII for intractable bleeding in patients without hemophilia: A developing country tertiary care center's experience.

Musallam KM, Saad GS, Majdalani MN, Muwakkit SA, Bou-Khalil PK, Aoun EG, Sawaya RA, Khalil I, Taher AT. Musallam KM, et al. Clin Appl Thromb Hemost. 2010 Dec;16(6):658-62. doi: 10.1177/1076029609343448. Epub 2009 Aug 10. Clin Appl Thromb Hemost. 2010. PMID: 19671562 Free article.

5

The clinical implications of angiogenesis in the treatment of cancer.

Aoun E, Taher A. Aoun E, et al. J Med Liban. 2002 Jan-Apr;50(1-2):32-8. J Med Liban. 2002. PMID: 12841311 Review.

6

Childhood stroke in a child with familial Mediterranean fever carrying several prothrombotic risk factors.

Aoun EG, Musallam KM, Uthman I, Beydoun A, El-Hajj T, Taher AT. Aoun EG, et al. Lupus. 2009 Aug;18(9):845-7. doi: 10.1177/0961203309103057. Lupus. 2009. PMID: 19578111

7

JAK2V617F and prothrombin G20210A gene mutations in a patient with Budd-Chiari syndrome and essential thrombocythemia.

Musallam KM, Aoun EG, Mahfouz RA, Khalife M, Taher AT. Musallam KM, et al. Clin Appl Thromb Hemost. 2010 Aug;16(4):472-4. doi: 10.1177/1076029609332110. Epub 2009 Feb 16. Clin Appl Thromb Hemost. 2010. PMID: 19223280 Free article.

8

Malignancy and hypercoagulability: a two-way association revisited.

Aoun EG, Musallam KM, Abou-Ghazal M, Taher AT. Aoun EG, et al. J Thromb Thrombolysis. 2010 Oct;30(3):340-1. doi: 10.1007/s11239-010-0458-4. J Thromb Thrombolysis. 2010. PMID: 20174855

9

Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection.

Inati A, Taher A, Ghorra S, Koussa S, Taha M, Aoun E, Sharara AI. Inati A, et al. Among authors: aoun e. Br J Haematol. 2005 Aug;130(4):644-6. doi: 10.1111/j.1365-2141.2005.05645.x. Br J Haematol. 2005. PMID: 16098081 Free article. Clinical Trial.

10

Ocular findings among thalassemia patients.

Taher A, Bashshur Z, Shamseddeen WA, Abdulnour RE, Aoun E, Koussa S, Baz P. Taher A, et al. Among authors: aoun e. Am J Ophthalmol. 2006 Oct;142(4):704-5. doi: 10.1016/j.ajo.2006.04.030. Am J Ophthalmol. 2006. PMID: 17011879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters